667 related articles for article (PubMed ID: 27112112)
1. Mechanism and kinetics of the loss of poorly soluble drugs from liposomal carriers studied by a novel flow field-flow fractionation-based drug release-/transfer-assay.
Hinna AH; Hupfeld S; Kuntsche J; Bauer-Brandl A; Brandl M
J Control Release; 2016 Jun; 232():228-37. PubMed ID: 27112112
[TBL] [Abstract][Full Text] [Related]
2. The use of asymmetrical flow field-flow fractionation with on-line detection in the study of drug retention within liposomal nanocarriers and drug transfer kinetics.
Hinna AH; Hupfeld S; Kuntsche J; Brandl M
J Pharm Biomed Anal; 2016 May; 124():157-163. PubMed ID: 26950903
[TBL] [Abstract][Full Text] [Related]
3. Asymmetrical flow field-flow fractionation with on-line detection for drug transfer studies: a feasibility study.
Hinna A; Steiniger F; Hupfeld S; Brandl M; Kuntsche J
Anal Bioanal Chem; 2014 Dec; 406(30):7827-39. PubMed ID: 24518901
[TBL] [Abstract][Full Text] [Related]
4. Application of Asymmetrical Flow Field-Flow Fractionation for Characterizing the Size and Drug Release Kinetics of Theranostic Lipid Nanovesicles.
Skupin-Mrugalska P; Elvang PA; Brandl M
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638795
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of temoporfin-loaded liposome formulations: correlation of liposome and temoporfin blood concentration.
Decker C; Schubert H; May S; Fahr A
J Control Release; 2013 Mar; 166(3):277-85. PubMed ID: 23313962
[TBL] [Abstract][Full Text] [Related]
6. Investigations of the influence of liposome composition on vesicle stability and drug transfer in human plasma: a transfer study.
Holzschuh S; Kaeß K; Bossa GV; Decker C; Fahr A; May S
J Liposome Res; 2018 Mar; 28(1):22-34. PubMed ID: 27750473
[TBL] [Abstract][Full Text] [Related]
7. Transfer mechanism of temoporfin between liposomal membranes.
Hefesha H; Loew S; Liu X; May S; Fahr A
J Control Release; 2011 Mar; 150(3):279-86. PubMed ID: 20888878
[TBL] [Abstract][Full Text] [Related]
8. Quantitative In Vitro Assessment of Liposome Stability and Drug Transfer Employing Asymmetrical Flow Field-Flow Fractionation (AF4).
Holzschuh S; Kaeß K; Fahr A; Decker C
Pharm Res; 2016 Apr; 33(4):842-55. PubMed ID: 26597938
[TBL] [Abstract][Full Text] [Related]
9. Transfer of lipophilic drugs between liposomal membranes and biological interfaces: consequences for drug delivery.
Fahr A; van Hoogevest P; May S; Bergstrand N; S Leigh ML
Eur J Pharm Sci; 2005 Nov; 26(3-4):251-65. PubMed ID: 16112849
[TBL] [Abstract][Full Text] [Related]
10. Drastic differences between the release kinetics of two highly related porphyrins in liposomal membranes: mTHPP and pTHPP.
Kuntsche J; Rajakulendran K; Sabriye HMT; Tawakal N; Khandelia H; Hakami Zanjani AA
J Colloid Interface Sci; 2023 Dec; 651():750-759. PubMed ID: 37572612
[TBL] [Abstract][Full Text] [Related]
11. Flow cytometry as a new approach to investigate drug transfer between lipid particles.
Petersen S; Fahr A; Bunjes H
Mol Pharm; 2010 Apr; 7(2):350-63. PubMed ID: 20063898
[TBL] [Abstract][Full Text] [Related]
12. A liposomal fluorescence assay to study permeation kinetics of drug-like weak bases across the lipid bilayer.
Eyer K; Paech F; Schuler F; Kuhn P; Kissner R; Belli S; Dittrich PS; Krämer SD
J Control Release; 2014 Jan; 173():102-9. PubMed ID: 24211703
[TBL] [Abstract][Full Text] [Related]
13. Lipophilic drug transfer between liposomal and biological membranes: what does it mean for parenteral and oral drug delivery?
Fahr A; van Hoogevest P; Kuntsche J; Leigh ML
J Liposome Res; 2006; 16(3):281-301. PubMed ID: 16952882
[TBL] [Abstract][Full Text] [Related]
14. Liposomal drugs dispersed in hydrogels. Effect of liposome, drug and gel properties on drug release kinetics.
Mourtas S; Fotopoulou S; Duraj S; Sfika V; Tsakiroglou C; Antimisiaris SG
Colloids Surf B Biointerfaces; 2007 Apr; 55(2):212-21. PubMed ID: 17223020
[TBL] [Abstract][Full Text] [Related]
15. Liposome transport of hydrophobic drugs: gel phase lipid bilayer permeability and partitioning of the lactone form of a hydrophobic camptothecin, DB-67.
Joguparthi V; Xiang TX; Anderson BD
J Pharm Sci; 2008 Jan; 97(1):400-20. PubMed ID: 17879989
[TBL] [Abstract][Full Text] [Related]
16. Tamoxifen in topical liposomes: development, characterization and in-vitro evaluation.
Bhatia A; Kumar R; Katare OP
J Pharm Pharm Sci; 2004 Jul; 7(2):252-9. PubMed ID: 15367383
[TBL] [Abstract][Full Text] [Related]
17. Microfluidics based manufacture of liposomes simultaneously entrapping hydrophilic and lipophilic drugs.
Joshi S; Hussain MT; Roces CB; Anderluzzi G; Kastner E; Salmaso S; Kirby DJ; Perrie Y
Int J Pharm; 2016 Nov; 514(1):160-168. PubMed ID: 27863660
[TBL] [Abstract][Full Text] [Related]
18. Transfer of a lipophilic drug (temoporfin) between small unilamellar liposomes and human plasma proteins: influence of membrane composition on vesicle integrity and release characteristics.
Decker C; Steiniger F; Fahr A
J Liposome Res; 2013 Jun; 23(2):154-65. PubMed ID: 23590339
[TBL] [Abstract][Full Text] [Related]
19. Enhanced active liposomal loading of a poorly soluble ionizable drug using supersaturated drug solutions.
Modi S; Xiang TX; Anderson BD
J Control Release; 2012 Sep; 162(2):330-9. PubMed ID: 22800581
[TBL] [Abstract][Full Text] [Related]
20. Characterization of drug release from liposomal formulations in ocular fluid.
Jafari MR; Jones AB; Hikal AH; Williamson JS; Wyandt CM
Drug Deliv; 1998; 5(4):227-38. PubMed ID: 19569989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
